BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 3933814)

  • 1. 12-O-tetradecanoylphorbol-13-acetate promotes tumors prior to initiation in two-stage promotion.
    Ordman AB; Cleaveland JS; Boutwell RK
    Cancer Lett; 1985 Oct; 29(1):79-84. PubMed ID: 3933814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of combined treatments with selenium, glutathione, and vitamin E on glutathione peroxidase activity, ornithine decarboxylase induction, and complete and multistage carcinogenesis in mouse skin.
    Perchellet JP; Abney NL; Thomas RM; Guislain YL; Perchellet EM
    Cancer Res; 1987 Jan; 47(2):477-85. PubMed ID: 3098411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of dose and duration of treatment with the tumor-promoting agent, 12-O-tetradecanoylphorbol-13-acetate on mouse skin carcinogenesis.
    Verma AK; Boutwell RK
    Carcinogenesis; 1980 Mar; 1(3):271-6. PubMed ID: 22283009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the mechanism of skin tumor promotion: evidence for several stages in promotion.
    Slaga TJ; Fischer SM; Nelson K; Gleason GL
    Proc Natl Acad Sci U S A; 1980 Jun; 77(6):3659-63. PubMed ID: 6774342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of mezerein-promoted papilloma formation by treatment with 12-O-tetradecanoylphorbol-13-acetate or mezerein prior to initiation.
    Ewing MW; Crysup SE; Phillips JL; Slaga TJ; DiGiovanni J
    Carcinogenesis; 1988 Mar; 9(3):405-10. PubMed ID: 3125993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. S/RV Cri-ba, a hairless mouse strain sensitive to skin tumorigenesis by suboptimal doses of 7,12-dimethylbenz[a]anthracene, initiation-promotion and two stage promotion protocols.
    Bhisey RA; Veturkar PL
    Cancer Lett; 1990 Jun; 52(1):63-9. PubMed ID: 2112980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of prostaglandin E1 in ornithine decarboxylase induction by tumor promoters.
    Ordman AB; Simsiman RC; Cleaveland JS; Boutwell RK
    Int J Cancer; 1986 Mar; 37(3):445-9. PubMed ID: 3081453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of 7-bromomethylbenz[a]anthracene-promoted mouse skin tumor formation by retinoic acid and dexamethasone.
    Verma AK; Garcia CT; Ashendel CL; Boutwell RK
    Cancer Res; 1983 Jul; 43(7):3045-9. PubMed ID: 6406052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Further characterization of skin tumor promotion and progression by mezerein in SENCAR mice.
    Ewing MW; Conti CJ; Phillips JL; Slaga TJ; DiGiovanni J
    J Natl Cancer Inst; 1989 May; 81(9):676-82. PubMed ID: 2496233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consumption of reduced-energy/low-fat diet or constant-energy/high-fat diet during mezerein treatment inhibited mouse skin tumor promotion.
    Birt DF; Pelling JC; Anderson J; Barnett T
    Carcinogenesis; 1994 Oct; 15(10):2341-5. PubMed ID: 7955075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin E is a complete tumor promoter in mouse skin.
    Mitchel RE; McCann R
    Carcinogenesis; 1993 Apr; 14(4):659-62. PubMed ID: 8472330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cepharanthine inhibits two-stage tumor promotion by 12-O-tetradecanoylphorbol 13-acetate and mezerein on skin tumor formation in mice initiated with 7,12-dimethylbenz[a]anthracene.
    Yasukawa K; Takido M; Takeuchi M; Akasu M; Nakagawa S
    J Cancer Res Clin Oncol; 1991; 117(5):421-4. PubMed ID: 1909698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholera toxin, a potent inducer of epidermal hyperplasia but with no tumor promoting activity in mouse skin carcinogenesis.
    Kuroki T; Chida K; Munakata K; Murakami Y
    Biochem Biophys Res Commun; 1986 May; 137(1):486-92. PubMed ID: 3013191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The protein kinase C activator L-alpha-dioctanoylglycerol: a potent stage II mouse skin tumor promoter.
    Verma AK
    Cancer Res; 1988 Apr; 48(7):1736-9. PubMed ID: 3127039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. alpha-Difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase, inhibits tumor promoter-induced polyamine accumulation and carcinogenesis in mouse skin.
    Weeks CE; Herrmann AL; Nelson FR; Slaga TJ
    Proc Natl Acad Sci U S A; 1982 Oct; 79(19):6028-32. PubMed ID: 6821130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A course of very small doses of DMBA, each of them allegedly with no promoting potency, acts with clear synergistic effect as a strong promoter of DMBA-initiated mouse skin carcinogenesis. A comparison of the tumorigenic and carcinogenic effects of DMBA (7,12-dimethylbenz-alpha-anthracene) and TPA (12-O-tetradecanoyl-phorbol-13-acetate) used as initiators and promoters in classical two-stage experimental protocols.
    Iversen OH
    APMIS Suppl; 1994; 41():1-38. PubMed ID: 7946481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 7,12-Dimethylbenz[a]anthracene/12-O-tetradecanoyl-phorbol-13-acetate-mediated skin tumor initiation and promotion in male Sprague-Dawley rats.
    Schweizer J; Loehrke H; Hesse B; Goerttler K
    Carcinogenesis; 1982; 3(7):785-9. PubMed ID: 6811148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of methoxychlor on skin tumor development.
    Dwivedi C; Tabbert J
    Toxicol Lett; 1994 Dec; 74(3):235-40. PubMed ID: 7871547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Only a subset of 12-O-tetradecanoylphorbol-13-acetate-promoted mouse skin papillomas are promotable by benzoyl peroxide.
    Mancuso M; Pazzaglia S; Tanori M; Rebessi S; Di Majo V; Covelli V; Saran A
    Mutat Res; 2004 Apr; 548(1-2):35-45. PubMed ID: 15063134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of ornithine decarboxylase in specific subpopulations of murine epidermal cells following multiple exposures to 12-O-tetradecanoylphorbol-13-acetate, mezerein and ethyl phenylpropriolate.
    Gilmour SK; Robertson FM; Megosh L; O'Connell SM; Mitchell J; O'Brien TG
    Carcinogenesis; 1992 Jan; 13(1):51-6. PubMed ID: 1733573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.